New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Interleukin Genetics Reports Third Quarter 2016 Financial Results
-
Global Survey Reveals Complexity, Change and Human Factors Are Key Causes of Today's Network Outages and Vulnerabilities
-
Veriflow Launches Disruptive Network Verification Platform and Announces Customer Wins
-
Long Hill Capital Closes $125M Fund to Invest in Healthcare and Consumer Services Start-ups in China
-
Aerospike Unveils New Release to Power Next Generation Digital Business Apps
-
Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia
-
Anaplan Selects Scout's Sourcing Technology to Help Manage Profitable Growth
-
EverBank, The Vail Valley Foundation and EverFi Team up to Offer Students a Chance to Win a Trip to the 2016 Audi FIS Birds of Prey World Cup Through Financial Literacy
-
Form SC 13D Ra Pharmaceuticals, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Medicines and Healthcare Products Regulatory Agency ("MHRA") Designates VTS-270 as a Promising Innovative Medicine
-
Form 4 Ra Pharmaceuticals, Inc. For: Oct 31 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
NEA Promotes Makhzoumi And Puttagunta To General Partner; Chang Named Chairman And Head, Asia
-
REMINDER - MOVE Guides Webinar to Highlight Benefits of Instant Cost Estimates for Employee Assignments and Relocations
-
Aerospike Named in Five Gartner Hype Cycle Reports
-
At Least 55 Percent of Uninsured Gig Workers Plan to Get Health Coverage in 2017
-
Veriflow Wins Barclays 2016 Open Innovation Challenge Award
-
MOVE Guides Webinar to Highlight Benefits of Instant Cost Estimates for Employee Assignments and Relocations
-
Sonatype Adds npm & JavaScript Intelligence to Nexus Platform
-
PlacementTracker Publishes Q3 2016 Private Placement Market League Tables
-
NEA Names Vanessa Larco As Partner
-
Form 4 XTERA COMMUNICATIONS, For: Oct 11 Filed by: NEW ENTERPRISE ASSOCIATES 9 L P
-
Relievant Medsystems, Inc. Secures $36 Million in Equity Financing for INTRACEPT® Clinical Development and Commercial Launch Preparation
-
Welltok Raises $33.7 Million to Optimize Consumer Health
-
Vtesse Announces Dosing of First Patient in Germany for Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease
-
Form SC 13D/A XTERA COMMUNICATIONS, Filed by: NEW ENTERPRISE ASSOCIATES 9 L P
-
Form 4/A Roka BioScience, Inc. For: Sep 21 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form 4 XTERA COMMUNICATIONS, For: Sep 27 Filed by: NEW ENTERPRISE ASSOCIATES 9 L P
-
Form SC 13D/A Roka BioScience, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
MOVE Guides to Share How Technology Powers Global Mobility at ERC's 2016 Global Workforce Symposium
-
Rotation Medical Bioinductive Implant Helps Patients with Rotator Cuff Tears Grow New Tendinous Tissue
-
New Security Startup Expel Secures $7.5 Million Series A Financing
-
Canvas Ventures Raises $300M Fund to Invest in Software & Services Startups
-
Form 4 Roka BioScience, Inc. For: Sep 21 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Introducing Zero: Acts Like a Debit Card, Earns Credit Card Rewards
-
Big Data and Artificial Intelligence Hold Greatest Promise for Healthcare Technologies, According to Silicon Valley Bank Survey
-
Metromile Announces $191.5M in Funding; Acquires Insurance Carrier
-
Form SC 13D/A PROTEOSTASIS THERAPEUTIC Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13D/A DASAN ZHONE SOLUTIONS Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Madrigal Pharma (MDGL), Tarveda Therapeutics Announce Exclusive License Agreement for HSP90 Program
-
Madrigal Pharmaceuticals and Tarveda Therapeutics Announce Exclusive License Agreement for HSP90 Drug Conjugate Oncology Platform
-
Anti-Infectives Rx Will Bring Together Leading Experts in Anti-Infective, Antiviral, and Antibacterial Therapies for Networking Conference in Boston
-
Form 4 XTERA COMMUNICATIONS, For: Sep 13 Filed by: NEW ENTERPRISE ASSOCIATES 9 L P
-
Sonatype Introduces Nexus Repository Integration with CloudBees Jenkins
-
Form SC 13D/A Loxo Oncology, Inc. Filed by: New Enterprise Associates 14, L.P.
-
MOVE Guides Named Relocation Management Company of the Year in APAC at Expatriate Management & Mobility Awards
-
New StreamSets Dataflow Performance Manager(TM) Unifies Operational Control Over Data in Motion
-
Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic
-
Cyence Launches from Stealth with Economic Cyber Risk Modeling Platform
-
Cyence Launches from Stealth with Economic Cyber Risk Modeling Platform
-
Rotation Medical Bioinductive Implant Induces New Tissue Formation in Patients with Partial-Thickness Rotator Cuff Tears

